Catalyst Health Solutions, SXC Health Solutions deal

SXC completed its acquisition of fellow pharmacy benefit manager Catalyst in a cash and stock deal that values Catalyst at $81.02 per share, or about $4.4 billion (see BioCentury, April 23). ...